ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,569.90
-1.23%
S&P ASX All Technology
2,968.80
-1.53%
Brent Oil
85.215
-0.79%
US Dollar vs AUD
1.5433
-0.06%
Bitcoin
57,586.80
-4.97%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Royalty Pharma PLC (RPRX)

  7. Royalty Pharma PLC (RPRX) News

RPRX Royalty Pharma PLC

27.70
0.00 (0.00%)
Pre Market
Last Updated: 21:00:05
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Royalty Pharma PLC RPRX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 27.70 21:00:05
Open Price Low Price High Price Close Price Previous Close
27.70
more quote information »

Recent News

Date Time Source Heading
19/4/202422:15GLOBERoyalty Pharma to Announce First Quarter 2024 Financial..
17/4/202422:15GLOBERoyalty Pharma Declares Second Quarter 2024 Dividend
29/2/202408:15GLOBERoyalty Pharma to Present at TD Cowen’s 44th Annual Health..
16/2/202401:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202423:33EDGAR2Form 8-K - Current report
15/2/202423:30GLOBERoyalty Pharma Reports Q4 and Full Year 2023 Results
06/2/202423:01EDGAR2Form 8-K - Current report
31/1/202408:15GLOBERoyalty Pharma To Announce Fourth Quarter And Full Year 2023..
20/1/202400:15GLOBERoyalty Pharma Announces Dividend Increase
08/1/202423:18EDGAR2Form 8-K - Current report
08/1/202423:00GLOBERoyalty Pharma Highlights Accomplishments and Provides..
04/1/202408:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202408:30EDGAR2Form 144 - Report of proposed sale of securities
30/12/202308:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202308:31EDGAR2Form 8-K - Current report
28/12/202305:05EDGAR2Form 8-K - Current report
20/12/202308:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202308:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202308:47EDGAR2Form 144 - Report of proposed sale of securities
28/11/202308:15GLOBERoyalty Pharma to Present at the Evercore ISI 6th Annual..
17/11/202309:16EDGAR2Form 8-K - Current report
17/11/202309:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/11/202311:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202300:10GLOBERoyalty Pharma and Teva Collaborate to Further Accelerate..
14/11/202300:00BWTeva and Royalty Pharma Collaborate to Further Accelerate..
09/11/202301:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202323:40EDGAR2Form 8-K - Current report
08/11/202323:00GLOBERoyalty Pharma Reports Third Quarter 2023 Results
20/10/202300:29EDGAR2Form 8-K - Current report
19/10/202322:59GLOBERoyalty Pharma Announces Agreement to Purchase Up to $1.5..
17/10/202307:15GLOBERoyalty Pharma Declares Fourth Quarter 2023 Dividend
12/10/202307:15GLOBERoyalty Pharma To Announce Third Quarter 2023 Financial..
04/10/202307:15EDGAR2Form 144 - Report of proposed sale of securities
04/10/202307:15EDGAR2Form 144 - Report of proposed sale of securities
21/9/202322:25GLOBERoyalty Pharma Appoints Eric Schneider as Chief Technology..
06/9/202306:15GLOBERoyalty Pharma and Ascendis Pharma Enter Into $150 Million..
06/9/202306:01GLOBEAscendis Pharma and Royalty Pharma Enter into $150 Million..
05/9/202322:25GLOBERoyalty Pharma to Present at Upcoming Investor Conferences
24/8/202320:30GLOBERoyalty Pharma and Ferring Pharmaceuticals Enter Into US..
24/8/202315:15BWRoyalty Pharma and Ferring Pharmaceuticals Enter into US..
12/8/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202306:45EDGAR2Form 144 - Report of proposed sale of securities
09/8/202307:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202307:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202323:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202321:31EDGAR2Form 8-K - Current report
08/8/202321:00GLOBERoyalty Pharma Reports Second Quarter 2023 Results
19/7/202306:15GLOBERoyalty Pharma to Announce Second Quarter 2023 Financial..
18/7/202306:15GLOBERoyalty Pharma Declares Third Quarter 2023 Dividend
15/7/202308:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

NASDAQ
RPRX
Royalty Pharma
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved